About OptimizeRx Corp
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.optimizerx.com/
Frequently Asked Questions
What is the 52-week range for OPRX?
The 52-week high is $22.25 and the 52-week low is $4.54.
What is the P/E ratio for OPRX?
The Price to Earnings (P/E) ratio is 35.08.
What is the dividend yield for OPRX?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 3.60%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 4.66%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.78.
Analyst Recommendation Trends
Wall Street analyst consensus for OPRX over the last few months:
Latest OPRX News
What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For Shareholders
In September 2026, OptimizeRx Corp. announced it had integrated its authenticated point of care inventory with The Trade Desk’s OpenPath, giving advertisers direct programmatic access via The Trade Desk’s demand side platform to a proprietary healthcare network spanning more than 400 EHR and e-prescribe systems and 800,000 verified healthcare professionals. This move deepens The Trade Desk’s healthcare-focused inventory and could make its platform more attractive to life sciences advertisers...
B. Riley Securities Maintains Buy on OptimizeRx, Raises Price Target to $11
B. Riley Securities analyst Anderson Schock maintains OptimizeRx (NASDAQ:OPRX) with a Buy and raises the price target from $10 to $11.
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
The Trade Desk expands healthcare advertising with OptimizeRx, adding authenticated HCP inventory across 400+ EHR and e-prescribing systems.
OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network
The move gives life sciences advertisers a more streamlined way to bring specialized healthcare audiences into their broader digital media strategies.
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade DeskWALTHAM, Mass., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at critical decision points, today announced an integration with OpenPath, The T
OptimizeRx: Gross Margin Gains And Improved Long-Term Outlook
OptimizeRx is upgraded to a Buy rating on a stronger 2027 growth outlook, rising margins, and cheap valuation. Learn more about OPRX stock here.
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflowWALTHAM, Mass., Sept. 14, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision points has expanded its patent-pending, AI-powered Natural Language Audience Builder (NLAB)
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced that management will participate in the 10th Annual Lake Street Capital Best Ideas Growth Conference taking place Thursday, September 10, 2026, in New York, NY. To request a meeting or for more details about the
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-10-01 | D'Silva Andrew J. | -414 | $8.39 | $3,473 |
| 2026-09-01 | D'Silva Andrew J. | -1,432 | $7.86 | $11,256 |
| 2026-08-21 | Merrell Brendan W. | -1,020 | $7.71 | $7,864 |
| 2026-08-21 | Silvestro Stephen L | -1,737 | $7.71 | $13,392 |
| 2026-08-21 | Odence-Ford Marion | -1,529 | $7.71 | $11,789 |
| 2026-08-21 | D'Silva Andrew J. | -1,243 | $7.71 | $9,584 |
| 2026-08-21 | Stelmakh Edward | -1,381 | $7.71 | $10,648 |
| 2026-08-20 | Silvestro Stephen L | +79,200 | - | - |
| 2026-08-20 | D'Silva Andrew J. | +57,600 | - | - |
| 2026-08-20 | Merrell Brendan W. | +57,600 | - | - |
| 2026-08-20 | Odence-Ford Marion | +57,600 | - | - |
| 2026-06-09 | Lang James Paul | +34,517 | - | - |
| 2026-06-09 | Presti Mariyamma Varghese | +17,258 | - | - |
| 2026-06-09 | Vos Ellen O'Connor | +34,517 | - | - |
| 2026-06-09 | Spangler Patrick D | +34,517 | - | - |
| 2026-06-09 | WASSON GREGORY D | +34,517 | - | - |
| 2026-06-09 | KLEMA CATHY | +34,517 | - | - |
| 2026-05-15 | Greco Theresa | -879 | $5.21 | $4,580 |
| 2026-05-15 | Greco Theresa | -914 | $5.21 | $4,762 |
| 2026-05-15 | Silvestro Stephen L | -5,219 | $5.21 | $27,191 |
| 2026-05-01 | Presti Mariyamma Varghese | +13,060 | - | - |
| 2026-02-11 | Odence-Ford Marion | -4,000 | - | - |
| 2026-02-11 | Odence-Ford Marion | -1,386 | $9.23 | $12,793 |
| 2026-02-11 | Odence-Ford Marion | +4,000 | - | - |
| 2025-12-23 | Silvestro Stephen L | -3,361 | $12.74 | $42,819 |
| 2025-12-23 | Greco Theresa | -1,420 | $12.74 | $18,091 |
| 2025-12-23 | Silvestro Stephen L | -3,361 | $12.74 | $42,819 |
| 2025-12-23 | Odence-Ford Marion | -4,051 | $12.74 | $51,610 |
| 2025-12-23 | Besch Doug | -4,079 | $12.74 | $51,966 |
| 2025-12-23 | Stelmakh Edward | -3,658 | $12.74 | $46,603 |
| 2025-12-19 | Stelmakh Edward | -5,237 | - | - |
| 2025-12-19 | Stelmakh Edward | -1,388 | $13.51 | $18,752 |
| 2025-12-19 | Stelmakh Edward | +5,237 | - | - |
| 2025-12-19 | Stelmakh Edward | -5,237 | - | - |
| 2025-12-19 | Stelmakh Edward | -1,388 | $13.51 | $18,752 |
| 2025-12-19 | Stelmakh Edward | +5,237 | - | - |
| 2025-12-19 | Silvestro Stephen L | -6,546 | - | - |
| 2025-12-19 | Silvestro Stephen L | -1,594 | $13.51 | $21,535 |
| 2025-12-19 | Silvestro Stephen L | +6,546 | - | - |
| 2025-12-19 | Odence-Ford Marion | -3,928 | - | - |
| 2025-12-19 | Odence-Ford Marion | -1,153 | $13.51 | $15,577 |
| 2025-12-19 | Odence-Ford Marion | +3,928 | - | - |
| 2025-12-19 | Merrell Brendan W. | -289 | $13.51 | $3,904 |
| 2025-12-19 | D'Silva Andrew J. | -703 | $13.51 | $9,498 |
| 2025-12-19 | Besch Doug | -1,964 | - | - |
| 2025-12-19 | Besch Doug | -581 | $13.51 | $7,849 |
| 2025-12-19 | Besch Doug | +1,964 | - | - |
| 2025-12-11 | Merrell Brendan W. | -712 | $14.03 | $9,989 |
| 2025-12-11 | D'Silva Andrew J. | -868 | $14.03 | $12,178 |
| 2025-11-01 | Greco Theresa | -1,693 | $20.49 | $34,690 |